BROMAZOLAM

1195000

BROMAZOLAM is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties, it was never FDA approved and was never available to the public. This product is intended for laboratory research purposes only

Clear
SKU: BROMAZOLAM Category:

Bromazolam (XLI-268) is a benzodiazepine derivative which was first synthesised in 1976, but was never marketed. It has subsequently been sold as a designer drug, first being definitively identified by the EMCDDA in Sweden in 2016. It is the bromo instead of chloro analogue of alprazolam, and has similar sedative and anxiolytic effects.Bromazolam is a non subtype selective agonist at the benzodiazepine site of GABAA receptors, with a binding affinity of 2.81nM at the α1 subtype, 0.69nM at α2 and 0.62nM at α5.

Disclaimer

BROMAZOLAM is for research use – Not for human or veterinary diagnostic or therapeutic use. It is the responsibility of the purchaser to determine suitability for other applications.

Iupac name

8-bromo-1-methyl-6-phenyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine

Chemical Formula

C17H13BrN4

Molecular Weight

353.22

Exact Mass

352.03

Reviews

There are no reviews yet.

Be the first to review “BROMAZOLAM”

Your email address will not be published. Required fields are marked *